Probably more important right now for investors is what is RC220 worth just as an anticancer drug. This is proven since RC220 is just RC110 without the crystallisation for anticancer purposes and any future clinical trials for anticancer (say AML) are just a matter of running through the motions.
My opinion only is that RC220 as an anticancer drug only worth around $4-$5. Would love to hear what other shareholders thinking including you Dr T.
RAC Price at posting:
$1.42 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
.
(20min delay)